Experimental Services.

22 CCR 51056.1

Source text

10 segments

22 CCR 51056.1

§ 51056.1. Experimental Services.

(a)

Experimental services means those drugs, equipment, procedures or services that are in a testing phase undergoing laboratory and/or animal studies prior to testing in humans.

(b)

Investigational services means those drugs, equipment, procedures or services for which laboratory and animal studies have been completed and for which human studies are in progress but:

(1)

Testing is not complete; and

(2)

The efficacy and safety of such services in human subjects are not yet established; and

(3)

The service is not in wide usage.

(c)

The determination that a service is experimental or investigational is based on:

(1)

Reference to relevant federal regulations, such as those contained in Title 42, Code of Federal Regulations, Chapter IV (Health Care Financing Administration) and Title 21, Code of Federal Regulations, Chapter I (Food and Drug Administration);

(2)

Consultation with provider organizations, academic and professional specialists pertinent to the specific service;

(3)

Reference to current medical literature.

Source outline

9 anchors in this source